US5530003A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical compositions for curing rheumatism
Assignee: Dott Co Ltd
•
Filing: 1993-04-30
•
Granted: 1996-06-25
•
Expires: 2013-04-30
Abstract
Abstract Disclosed is a novel agent for curing rheumatism, which consists of a pharmaceutical composition containing 5-fluorouracil or an N-derivative thereof to be converted into 5-fluorouracil within the body, which is less in side effects, which has a high degree of safety, and which is high in curing effects.
Inventors
- 👤 Akira Yanagawa
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 03:53
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/33; A61K31/395; A61K31/495; A61K31/505; A61P; A61P29/00; C; C07; C07D; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/46; C07D239/52; C07D239/54; C07D239/545; C07D239/553; C07D405/00; C07D405/02; C07D405/04
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
34 words
A pharmaceutical composition for alleviating the symptoms of rheumatism comprising (1) an active ingredient selected from the group 5-fluorouracil and N-derivatives of 5-fluorouracil which are converted into 5-fluorouracil within the body and (2) uracil.
Claim 2
Dependent Claim
34 words
A pharmaceutical composition for alleviating the symptoms of rheumatism comprising (1) an active ingredient selected from the group 5-fluorouracil and N-derivatives of 5-fluorouracil which are converted into 5-fluorouracil within the body and (2) uracil.
Claim 3
Dependent Claim
14 words
A pharmaceutical composition as claimed in claim 1 wherein said active ingredient is tegafur.
Claim 4
Independent Claim
46 words
A method for alleviating the symptoms of rheumatism in a patient comprising administering to said patient a pharmaceutical composition comprising (1) an active ingredient selected from the group consisting of 5-fluorouracil and N-derivatives of 5-fluorouracil which are converted into 5-fluorouracil within the body and (2) uracil.
Claim 5
Independent Claim
46 words
A method for alleviating the symptoms of rheumatism in a patient comprising administering to said patient a pharmaceutical composition comprising (1) an active ingredient selected from the group consisting of 5-fluorouracil and N-derivatives of 5-fluorouracil which are converted into 5-fluorouracil within the body and (2) uracil.
Claim 6
Dependent Claim
11 words
The method of claim 3 wherein said active ingredient is tegafur.
Claim 7
Dependent Claim
23 words
The method of claim 3 wherein said administering is by an oral daily dosage of 300 mg to 1200 mg of said composition.
Claim 8
Dependent Claim
11 words
The method of claim 3 wherein said administering is by injection.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-06-25 | 1999-12-25 | 2000-06-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-06-25 | 2003-12-25 | 2004-06-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-06-25 | 2007-12-25 | 2008-06-25 | $7700.00 | Window Closed / Lapsed |